Looking forward to joining @Alnylam, @akceatx, @EidosTx, Corino and @pfizer tomorrow at @AmyloidosisSupp’s webinar. Intellia VP, Development Operations, Jeff Cehelsky will present our #CRISPR /Cas9 technology and treatment approach. Register here: https://t.co/7dpWqnDt2c #ATTR https://t.co/zkt4zYergL